Lobe Sciences Ltd. (CVE:LOBE) | WebDisclosure

Basculer en Français

10804	Companies
233788	Keywords
162475	Articles
124838	Press releases

Home
Companies
Lobe Sciences Ltd.

PRESS RELEASE

published on 04/23/2026 at 14:00, 3 months 12 days ago

Lobe Sciences Ltd. Comments on White House Executive Order Supporting Drug Development for Neurological and Mental Health Disorders
Lobe Sciences welcomes White House Executive Order supporting advancements in neurology and mental health treatments, focusing on scientific research and compound evaluation

Mental Health Neurology Thérapies Lobe Sciences White House Executive Order
BRIEF

published on 04/21/2026 at 12:05, 3 months 14 days ago

Lobe Sciences Ltd. Partners with Massive Intelligence for Investor Relations

Investor Relations Biopharmaceuticals Corporate Communications Lobe Sciences Massive Intelligence
BRIEF

published on 04/21/2026 at 12:05, 3 months 14 days ago

Lobe Sciences Ltd. s'associe à Massive Intelligence pour ses relations avec les investisseurs.

Relations Avec Les Investisseurs Produits Biopharmaceutiques Communications D'entreprise Sciences Du Lobe Intelligence Massive
PRESS RELEASE

published on 04/21/2026 at 12:00, 3 months 14 days ago

Lobe Sciences Ltd. Engages Massive Intelligence Pty Ltd for Investor Relations and Corporate Communications Services
Lobe Sciences engages Massive Intelligence for investor relations and corporate communications services. Massive Intelligence to provide promotional services via social media, email, and press releases

Investor Relations Biopharmaceutical Corporate Communications Lobe Sciences Massive Intelligence
BRIEF

published on 04/20/2026 at 12:05, 3 months 15 days ago

Lobe Sciences finalise un placement privé et publie une mise à jour de ses activités

Placement Privé Investissement Biopharmaceutique Sciences Du Lobe Traitement De La Drépanocytose Développement Du S-100
BRIEF

published on 04/20/2026 at 12:05, 3 months 15 days ago

Lobe Sciences Completes Private Placement and Provides Corporate Update

Private Placement Biopharmaceutical Investment Lobe Sciences Sickle Cell Treatment S-100 Development
PRESS RELEASE

published on 04/20/2026 at 12:00, 3 months 15 days ago

Lobe Sciences Ltd. Announces Closing of Non-Brokered Private Placement and Provides Corporate Update
Lobe Sciences Ltd. announces closing of non-brokered private placement offering to advance S-100 drug candidate for sickle cell disease treatment

Private Placement Biopharmaceutical Sickle Cell Disease Lobe Sciences Ltd. S-100 Drug Candidate
BRIEF

published on 04/11/2026 at 02:05, 3 months 24 days ago

Lobe Sciences Ltd. Announces Private Placement for $950,000

Private Placement Funding Canada Securities Laws Regulatory Approvals
BRIEF

published on 04/11/2026 at 02:05, 3 months 24 days ago

Lobe Sciences Ltd. annonce un placement privé de 950 000 $

Financement Placement Privé Canada Approbations Réglementaires Lois Sur Les Valeurs Mobilières
PRESS RELEASE

published on 04/11/2026 at 02:00, 3 months 24 days ago

Lobe Sciences Ltd. Announces Non-Brokered Private Placement
Lobe Sciences Ltd. announces non-brokered private placement offering to raise approximately $950,000 for working capital and corporate expenses. Focus on neurology and psychiatry therapies

Private Placement Psychiatry Neurology Thérapies Lobe Sciences Ltd.

Accesswire

Published on 08/05/2026 at 15:35, 2 hours 8 minutes ago

Electrovaya Announces date for Q3-2026 Financial Results & Conference Call
Published on 08/05/2026 at 15:00, 2 hours 43 minutes ago

Jaguar Health Satisfies Conditions for Receipt of Non-Dilutive $2 Million Holdback Payment from Future Pak for Commercial License to Mytesi and Canalevia-CA1
Published on 08/05/2026 at 14:00, 3 hours 43 minutes ago

Lobe Sciences Announces Results of Annual General and Special Meeting of Shareholders
Published on 08/05/2026 at 13:30, 4 hours 13 minutes ago

Nextech3D.ai Signs Strategic Partnership with F2B Services to Drive AI Software Adoption, Expand LED Display Opportunities and Accelerate Event Technology Growth
Published on 08/05/2026 at 13:30, 4 hours 13 minutes ago

International Battery Metals Announces First Quarter Fiscal 2027 Financial Results Conference Call and Webcast

View all ACCESSWIRE

EQS Group

Published on 08/05/2026 at 16:45, 58 minutes ago

P&F Products & Features GmbH Announces Acquisition of AVVie GmbH
Published on 08/05/2026 at 16:34, 1 hour 9 minutes ago

EQS-Adhoc: Deutsche Rohstoff AG: Increase of 2026 and 2027 Guidance and Expansion of Drilling Program; 2026 EBITDA increases to up to EUR 400 million
Published on 08/05/2026 at 16:16, 1 hour 26 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc
Published on 08/05/2026 at 16:14, 1 hour 28 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Senior plc
Published on 08/05/2026 at 16:13, 1 hour 29 minutes ago

Form 8.3 - The Vanguard Group, Inc.: SEGRO plc

Les Echos

Published on 08/05/2026 at 14:16, 3 hours 26 minutes ago

LNA Santé : Répartition de capital et des droits de vote attachés aux actions au 31/07/2026
Published on 08/05/2026 at 13:52, 3 hours 50 minutes ago

Disclosure of Share Capital and Voting Rights as of July 31, 2026
Published on 08/05/2026 at 13:52, 3 hours 50 minutes ago

Déclaration du nombre d’actions et droits de vote au 31 juillet 2026
Published on 08/05/2026 at 13:33, 4 hours 10 minutes ago

Actualisation du document d'enregistrement universel 2025
Published on 08/04/2026 at 19:16, 22 hours 27 minutes ago

Covivio - 2026 Half-year financial report

View all LES ECHOS COMFI WIRE